STOCK TITAN

Cloud Dx - CDXFF STOCK NEWS

Welcome to our dedicated page for Cloud Dx news (Ticker: CDXFF), a resource for investors and traders seeking the latest updates and insights on Cloud Dx stock.

Overview

Cloud DX (TSXV:CDX / OTCQB:CDXFF) is a North American digital healthcare platform specializing in remote patient monitoring, digital healthcare solutions, and telehealth services. Through its innovative Connected Health™ platform, Cloud DX empowers healthcare enterprises and care teams to remotely manage chronic conditions, deliver hospital-quality post-surgical care at home, and support patients in aging in place. This seamless integration of advanced medical devices with intuitive mobile applications ensures that both patients and providers can access real-time health data, fostering better outcomes and more effective care delivery.

Business Model and Solutions

Cloud DX operates on a diversified revenue model that blends subscription services, hardware sales, and professional services. The company’s Connected Health Kits, which include certified medical devices and connectivity solutions, are designed for a range of healthcare applications from chronic disease management to post-operative recovery. Their platform collects vital signs, administers patient surveys, and facilitates communication between patients and care professionals, ensuring timely interventions and continuous monitoring.

Market Position and Industry Impact

In an era where digital transformation is key to effective healthcare delivery, Cloud DX has carved out a significant niche. Its solutions reduce the need for hospitalization and re-admission, lower overall healthcare costs, and improve patient outcomes. By securing long-term contracts and renewals with hospitals, community paramedic services, primary care networks, and provincial health authorities, Cloud DX demonstrates a robust market presence. The company’s strategic partnerships with respected entities such as Medtronic Canada, Teladoc Health Canada, and Sanrai International further validate its position as an innovative player in the telehealth sector.

Technology and Operational Excellence

The Cloud DX platform is built on advanced, cloud-based technology that guarantees data security, scalability, and compliance with healthcare regulations. Its design integrates robust connectivity levels with easy-to-use mobile applications, allowing healthcare providers to remotely access critical patient information. This technological prowess ensures that the platform not only supports clinical decision making but also drives operational efficiencies, thereby enhancing overall healthcare delivery models.

Recognitions and Strategic Collaborations

Cloud DX has received numerous accolades that underscore its commitment to innovation. The company is a co-winner of the Qualcomm Tricorder XPRIZE, a recipient of the 2022 Top Innovator award by Canadian Business, a 2021 Edison Award winner, and was shortlisted as a Fast Company "World Changing Idea" finalist. These honors, coupled with its exclusive partnerships with key industry players, position Cloud DX as a trusted and forward-thinking provider in digital healthcare.

Key Business Highlights

  • Delivers an integrated remote patient monitoring platform that improves patient outcomes.
  • Diversifies revenue streams through subscriptions, hardware, and value-added professional services.
  • Enhances care coordination through robust, real-time data analytics and communication tools.
  • Builds strong industry partnerships and enjoys high contract renewal rates.
  • Earns recognition through numerous innovation awards, reinforcing its expertise in digital health.

Investor and Analyst Considerations

Investors and analysts examining Cloud DX will note its established market position and robust business model, which is supported by repeat contracts, strategic alliances, and technological innovation. The company exemplifies how digital transformation in healthcare can drive efficiency, improve patient care, and maintain consistent operational resiliency. Its ongoing innovation also underpins its potential to adapt effectively within the rapidly evolving telehealth landscape.

Rhea-AI Summary
Cloud DX Inc. announces a non-brokered private placement to raise up to $2.8 million through the issuance of units at $0.12 per unit. The company may oversubscribe by an additional $500,000. Insider participation is possible, and proceeds will be used for general working capital. Investors have converted $3,187,000 CAD into common shares at $0.154 CAD per share.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Cloud DX reports a high 2024 contract renewal rate, with 11 contracts renewed for Connected Health products and services generating $1.25 million CAD revenue. The company aims for 100% client contract renewal in Q1 2024, with 16 new contracts announced since January 1, 2024, totaling over $4.0M CAD.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.4%
Tags
none
-
Rhea-AI Summary
A group of investors, including board directors, converts $4.2 million in debt to shares at a premium price of $0.154/share. 97% of shares, totaling 26,411,896, are pooled and escrowed for 24 months. Shareholders can't sell unless price exceeds $0.50/share for 10 consecutive days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Cloud DX (CDXFF) signs a 5-year Master Deployment Agreement with the Ottawa Hospital Research Institute to provide remote patient monitoring technology for research projects, studies, and clinical trials. The agreement aims to streamline the purchase of Cloud DX Connected Health products and services for over 1,000 patients involved in various projects. Cloud DX has secured contracts worth over $2.8M CAD since January 1, 2024, and partnered with VHA Home HealthCare and Sanrai International.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Cloud DX announces new contracts worth $2.8 million CAD in 2024, including a 24-month agreement with Dr. Lee S. Freedman for remote patient monitoring services. The agreement values at $230,000 CAD and aims to enroll 125 patients with chronic conditions. Cloud DX's gross margins are reported at 77%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Cloud DX partners with Sanrai International to distribute Connected Health products in 65 countries, securing over $2.5 million CAD in new business. The partnership aims to focus on chronic illness and post-surgical recovery, leveraging Cloud DX's remote monitoring technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
News
Rhea-AI Summary
Cloud DX appoints technologist and angel investor Mr. Konstantin Othmer to the Board, replacing Mr. Neil Fraser. Othmer brings 40 years of experience in technology and investments, having worked with Apple Inc. and invested in market leaders like Android and Tesla. The appointment is subject to approval by the Toronto Venture Exchange.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.39%
Tags
management
-
Rhea-AI Summary
Cloud DX (TSXV:CDX)(OTCQB:CDXFF) received a purchase order for up to 300 Vitaliti™ Continuous Vital Sign Monitor Systems valued at approximately $770,000 CAD. The order includes a 50% deposit, with the balance paid on delivery in Q2 2024. The systems will be used in a groundbreaking multi-site academic study of post-surgical patients, and the company has announced over $2.5 million CAD in new business since January 1, 2024. The CEO stated that this deployment will move forward the state of the art in virtual care while also gathering data required for Health Canada and FDA regulatory approvals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Cloud DX Inc. (CDXFF) to participate in The Microcap Conference, with CEO Robert Kaul presenting. The event will take place on January 30, 31, and February 1, 2024, at Caesars Atlantic City Hotel & Casino in Atlantic City, NJ. Interested parties can register to attend and have one-on-one meetings with the management team.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-34.3%
Tags
none
Rhea-AI Summary
Cloud DX (TSXV:CDX)(OTCQB:CDXFF) announces a new contract with VHA Home HealthCare, a not-for-profit provider of home care nursing, rehab, and personal support services in Ontario. The contract includes the deployment of Cloud DX Connected Health remote care monitoring (RCM) services to a significant proportion of eligible clients, with an initial term of 24 months and mutually agreed extensions thereafter. Cloud DX also reported gross margins of 77% as of September 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Cloud Dx (CDXFF)?

The current stock price of Cloud Dx (CDXFF) is $0.084 as of February 7, 2025.

What is the market cap of Cloud Dx (CDXFF)?

The market cap of Cloud Dx (CDXFF) is approximately 8.7M.

What is Cloud DX’s primary business focus?

Cloud DX specializes in digital healthcare solutions, offering remote patient monitoring and telehealth services designed to manage chronic conditions and support post-surgical care at home.

How does Cloud DX generate its revenue?

The company operates on a diversified revenue model, deriving income from subscriptions for its remote monitoring platform, sales of Connected Health Kits, and professional service engagements.

Who are the typical customers of Cloud DX?

Cloud DX serves a wide range of customers including hospitals, community paramedic services, primary care networks, academic medical centers, and provincial health authorities across North America.

What benefits does the Cloud DX platform provide?

The platform enables real-time monitoring of patient vital signs, supports proactive healthcare intervention, reduces hospital readmissions, and enhances overall care coordination between patients and providers.

How does Cloud DX stand out in the competitive telehealth market?

Cloud DX distinguishes itself through its integrated, user-friendly technology, long-term strategic partnerships, high contract renewal rates, and multiple awards that recognize its innovation and effectiveness in digital healthcare.

What recognition has Cloud DX received for its innovations?

The company is a co-winner of the Qualcomm Tricorder XPRIZE, has been named a 2022 Top Innovator by Canadian Business, won a 2021 Edison Award, and was a finalist for Fast Company’s "World Changing Idea" award.

How do strategic partnerships influence Cloud DX's growth?

Strategic alliances with leading healthcare providers like Medtronic Canada and Teladoc Health Canada bolster the credibility of Cloud DX and help expand its reach, thereby reinforcing its market position and enabling continuous innovation.
Cloud Dx

OTC:CDXFF

CDXFF Rankings

CDXFF Stock Data

8.67M
59.65M
57.33%
Health Information Services
Healthcare
Link
Canada
Kitchener